DEF: Global Medical REIT Announces 2025 Annual Stockholder Meeting and Director Nominations

Global Medical REIT will hold its annual stockholder meeting virtually on May 14, 2025, to elect directors, approve executive compensation, and ratify the appointment of Deloitte & Touche LLP as its independent accounting firm.

Summary

• Global Medical REIT Inc. will hold its 2025 Annual Meeting of Stockholders virtually on May 14, 2025, at 10:00 a.m. (ET).
• Stockholders will vote to elect seven director nominees, approve named executive officer compensation, and ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the year ending December 31, 2025.
• The record date for determining stockholders eligible to vote is March 19, 2025.
• Stockholders can vote online, by phone, or by mail prior to the meeting, or virtually during the meeting.
• The Board of Directors recommends voting FOR all director nominees, FOR the advisory resolution on executive compensation, and FOR the ratification of Deloitte's appointment.
• In 2024, the company acquired an $80 million portfolio of healthcare facilities and entered into an agreement to acquire an additional $70 million of healthcare facilities.
• The weighted average interest rate on the company's indebtedness decreased from 3.83% as of December 31, 2023, to 3.75% as of December 31, 2024.
• The company's stock price decreased from $11.10 as of December 29, 2023, to $7.72 as of December 31, 2024.
• The company improved its overall GRESB score to 57 in 2024, reflecting activity for the previous year, an increase of 15 points since 2021.

Sentiment

Score: 6

Explanation: The document presents a mix of positive and negative information. While there are positive aspects such as acquisitions and debt management, the decrease in stock price and failure to meet AFFO targets temper the overall sentiment.

Positives

• The company was able to acquire an $80.3 million portfolio of healthcare facilities in 2024.
• The company entered into a contract to acquire an additional $69.6 million of healthcare facilities.
• The weighted average interest rate on the company's indebtedness decreased from 3.83% to 3.75% in 2024.
• The company improved its overall GRESB score to 57 in 2024, reflecting activity for the previous year, an increase of 15 points since 2021.

Negatives

• The company's common stock price decreased from $11.10 to $7.72 during 2024.
• The company's AFFO per share was $0.89, below the target of $0.95 per share in the 2024 Annual Incentive Plan.

Risks

• The company's obligations to close on the remaining two properties in the Five-Property Portfolio are subject to certain customary terms and conditions, and there is no assurance that the Company will close the remainder of this acquisition on a timely basis, or at all.
• The company's cost of equity increased due to a decrease in the price of the company's common stock, tempering any positive changes to the cost of capital resulting from reduced short-term interest rates.

Future Outlook

The Company expects to close on the remaining two properties in the Five-Property Portfolio during the first half of 2025, subject to customary terms and conditions.

Management Comments

• We believe that the online tools we have selected will facilitate stockholder communication, allowing stockholders to communicate with us in advance of, and during, the Annual Meeting.
• The Company believes the acquisition of these two portfolios demonstrates its ability to source accretive, high-quality deals despite its elevated cost of capital.

Industry Context

The document mentions the Federal Reserve lowering the Federal Funds Rate and its impact on interest rates, which is relevant to the broader REIT industry. It also references the Dow Jones U.S. Real Estate Healthcare Index for relative performance comparisons.

Comparison to Industry Standards

• The document compares the company's performance against the Dow Jones U.S. Real Estate Healthcare Index for relative total stockholder return.
• The peer group for compensation benchmarking includes American Healthcare REIT, CareTrust REIT, National Health Investors, and Sabra Health Care REIT, among others.
• The company utilizes the ENERGY STAR platform to track energy consumption and has earned ENERGY STAR certifications for several facilities, indicating a focus on sustainability similar to industry peers.
• The company improved its overall GRESB score to 57 in 2024, reflecting activity for the previous year, an increase of 15 points since 2021.

Related Party Transactions

• Mr. Brandon Cole, the son of Mr. Henry Cole, is employed by the Company as its Director of Operations and earned approximately $160,000 in 2024.

Stakeholder Impact

• Stockholders are asked to vote on key proposals that will impact the company's governance and executive compensation.
• Employees are impacted by the company's compensation policies and sustainability efforts.
• Tenants are impacted by the company's sustainability efforts.
• The company's performance impacts its ability to provide returns to shareholders.

Next Steps

• Stockholders are encouraged to vote on the proposals outlined in the proxy statement.
• The company will hold its Annual Meeting on May 14, 2025.
• The company will continue to work towards closing the acquisition of the remaining properties in the Five-Property Portfolio.

Key Dates

Keywords

annual meeting, proxy statement, directors, executive compensation, Deloitte & Touche LLP, Global Medical REIT, healthcare facilities, stockholders